top of page

The Genetic Disease Company

GeneToBe's Mission

Preclinical and Clinical Stage Assets
Proof of concept in preclinical in vivo models
Next generation CRISPR/Cas9 platform (miCas9)
Create translational genetic disease models for demonstrating preclinical efficacy

Team with over 150 years’ experience in drug discovery, development, registration, and commercialization that has produced multiple registered pharmaceutical products and candidates


bottom of page